Helmy Eltoukhy, Co-Chief Executive Officer at Guardant Health, Inc. (GH), sold 600,000 shares at $59.44 ($35.7M) on 2025-09-09, disclosed to the SEC on 2025-09-11.
Open-market sale of $35.7M GH by Co-Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $59.44 | 294,723 | $17.5M | 49.1% |
| 2 | $59.44 | 294,723 | $17.5M | 49.1% |
| 3 | $59.93 | 5,277 | $316K | 0.9% |
| 4 | $59.93 | 5,277 | $316K | 0.9% |
| Total | $59.45 avg | 600,000 | $35.7M | 100% |
| Filing → |
| GH | BUY | 2023-03-16 | $4.7M | — | Filing → |
| GH | BUY | 2021-11-23 | $17.7M | — | Filing → |
| GH | SELL | 2021-04-26 | $2.6M | — | Filing → |